Contribution of long noncoding RNAs to autism spectrum disorder risk

International Review of Neurobiology

Volumn 113, Issue , 2013, Pages 35-59

  Wilkinson, Brent ^a,b   Campbell, Daniel B ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Biomarkers; Epigenetics; Gene regulation; LncRNA; Long noncoding RNA; NcRNA; Noncoding RNA; Transcriptional regulation

Indexed keywords

BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN; DOUBLE STRANDED RNA; EPIDERMAL GROWTH FACTOR RECEPTOR 4; FRAGILE X MENTAL RETARDATION PROTEIN; LONG UNTRANSLATED RNA; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PIWI PROTEIN; SMALL INTERFERING RNA; SMALL NUCLEOLAR RNA; SMALL UNTRANSLATED RNA;

ALTERNATIVE RNA SPLICING; ARTICLE; ASFMR1 GENE; AUTISM; BACE1 GENE; BC200 GENE; BDNF GENE; BRAIN DEVELOPMENT; BRAIN DISEASE; BRAIN FUNCTION; CANCER GENETICS; DEGENERATIVE DISEASE; DEVELOPMENTAL DISORDER; DISC1 GENE; DISEASE ASSOCIATION; DISEASE COURSE; EPIGENETICS; ERBB4 GENE; EVF2 GENE; FMR1 GENE; GENE; GENE FUNCTION; GENE LOCATION; GENETIC RISK; HOTAIR GENE; HUMAN; HUMAN GENOME; MEG3 GENE; MOLECULAR GENETICS; MSNP1AS GENE; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN RNA BINDING; PTEN GENE; RNA CLEAVAGE; RNA SEQUENCE; RNA TRANSCRIPTION; UBE3A GENE; X CHROMOSOME INACTIVATION;

BIOMARKERS; EPIGENETICS; GENE REGULATION; LNCRNA; LONG NONCODING RNA; NCRNA; NONCODING RNA; TRANSCRIPTIONAL REGULATION;

CHILD DEVELOPMENT DISORDERS, PERVASIVE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; RNA, LONG NONCODING;

EID: 84888427237     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-418700-9.00002-2     Document Type: Chapter

References (173)

1. Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., et al. Clustering and conservation patterns of human microRNAs. Nucleic Acids Research 2005, 33:2697-2706.
2. Alvarez-Garcia I., Miska E.A. MicroRNA functions in animal development and human disease. Development 2005, 132:4653-4662.
3. Amaral P.P., Neyt C., Wilkins S.J., Askarian-Amiri M.E., Sunkin S.M., Perkins A.C., et al. Complex architecture and regulated expression of the Sox2ot locus during vertebrate development. RNA 2009, 15:2013-2027.
4. Amiri A., Cho W., Zhou J., Birnbaum S.G., Sinton C.M., McKay R.M., et al. Pten deletion in adult hippocampal neural stem/progenitor cells causes cellular abnormalities and alters neurogenesis. Journal of Neuroscience 2012, 32:5880-5890.
5. Anderson S.A., Eisenstat D.D., Shi L., Rubenstein J.L. Interneuron migration from basal forebrain to neocortex: Dependence on Dlx genes. Science 1997, 278:474-476.
6. Ashley-Koch A.E., Jaworski J., Ma, de Q., Mei H., Ritchie M.D., Skaar D.A., et al. Investigation of potential gene-gene interactions between APOE and RELN contributing to autism risk. Psychiatric Genetics 2007, 17:221-226.
7. Atwal J.K., Chen Y., Chiu C., Mortensen D.L., Meilandt W.J., Liu Y., et al. A therapeutic antibody targeting BACE1 inhibits amyloid-β production in vivo. Science Translational Medicine 2011, 3:84ra43.
8. Babiarz J.E., Ruby J.G., Wang Y., Bartel D.P., Blelloch R. Mouse ES cells express endogenous shRNAs, siRNAs, and other Microprocessor-independent, Dicer-dependent small RNAs. Genes and Development 2008, 22:2773-2785.
9. Barry G., Briggs J.A., Vanichkina D.P., Poth E.M., Beveridge N.J., Ratnu V.S., et al. The long non-coding RNA Gomafu is acutely regulated in response to neuronal activation and involved in schizophrenia-associated alternative splicing. Molecular Psychiatry 2013, 10.1038/mp.2013.45.
10. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R.H., Cuppen E. Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005, 120:21-24.
11. Bernard D., Prasanth K.V., Tripathi V., Colasse S., Nakamura T., Xuan Z., et al. A long nuclear-retained non-coding RNA regulates synaptogenesis by modulating gene expression. The EMBO Journal 2010, 29:3082-3093.
12. Bertone P., Stolc V., Royce T.E., Rozowsky J.S., Urban A.E., Zhu X., et al. Global identification of human transcribed sequences with genome tiling arrays. Science 2004, 306:2242-2246.
13. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigó R., Gingeras T.R., Margulies E.H., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816.
14. Bond A.M., Vangompel M.J., Sametsky E.A., Clark M.F., Savage J.C., Disterhoft J.F., et al. Balanced gene regulation by an embryonic brain ncRNA is critical for adult hippocampal GABA circuitry. Nature Neuroscience 2009, 12:1020-1027.
15. Bourgeron T. A synaptic trek to autism. Current Opinion in Neurobiology 2009, 19:231-234.
16. Brown S.D. XIST and the mapping of the X chromosome inactivation centre. Bioessays 1991, 13:607-612.
17. Brown C.J., Hendrich B.D., Rupert J.L., Lafrenière R.G., Xing Y., Lawrence J., et al. The human XIST gene: Analysis of a 17kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell 1992, 71:527-542.
18. Burnett J.C., Rossi J.J. RNA-based therapeutics: Current progress and future prospects. Chemistry and Biology 2012, 19:60-71.
19. Butler M.G., Dasouki M.J., Zhou X.P., Talebizadeh Z., Brown M., Takahashi T.N., et al. Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics 2005, 42:318-321.
20. Cai H., Wang Y., McCarthy D., Wen H., Borchelt D.R., Price D.L., et al. BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nature Neuroscience 2001, 4:233-234.
21. Cairns P., Okami K., Halachmi S., Halachmi N., Esteller M., Herman J.G., et al. Frequent inactivation of PTEN/MMAC1 in primary prostate cancer. Cancer Research 1997, 57:4997-5000.
22. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., et al. The transcriptional landscape of the mammalian genome. Science 2005, 309:1559-1563.
23. Carninci P., Sandelin A., Lenhard B., Katayama S., Shimokawa K., Ponjavic J., et al. Genome-wide analysis of mammalian promoter architecture and evolution. Nature Genetics 2006, 38:626-635.
24. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
25. Chan A.S., Thorner P.S., Squire J.A., Zielenska M. Identification of a novel gene NCRMS on chromosome 12q21 with differential expression between rhabdomyosarcoma subtypes. Oncogene 2002, 21:3029-3037.
26. Chan W.L., Yuo C.Y., Yang W.K., Hung S.Y., Chang Y.S., Chiu C.C., et al. Transcribed pseudogene ψPPM1K generates endogenous siRNA to suppress oncogenic cell growth in hepatocellular carcinoma. Nucleic Acids Research 2013, 41:3734-3747.
27. Cheng J., Kapranov P., Drenkow J., Dike S., Brubaker S., Patel S., et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science 2005, 308:1149-1154.
28. Chodroff R.A., Goodstadt L., Sirey T.M., Oliver P.L., Davies K.E., Green E.D., et al. Long noncoding RNA genes: Conservation of sequence and brain expression among diverse amniotes. Genome Biology 2010, 11:R72.
29. Chung W.J., Okamura K., Martin R., Lai E.C. Endogenous RNA interference provides a somatic defense against Drosophila transposons. Current Biology 2008, 18:795-802.
30. Core L.J., Waterfall J.J., Lis J.T. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science 2008, 322:1845-1848.
31. de la Grange P., Gratadou L., Delord M., Dutertre M., Auboeuf D. Splicing factor and exon profiling across human tissues. Nucleic Acids Research 2010, 38:2825-2838.
32. Djebali S., Davis C.A., Merkel A., Dobin A., Lassmann T., Mortazavi A., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
33. Eastwood S.L., Harrison P.J. Cellular basis of reduced cortical reelin expression in schizophrenia. The American Journal of Psychiatry 2006, 163:540-542.
34. Egan M.F., Kojima M., Callicott J.H., Goldberg T.E., Kolachana B.S., Bertolino A., et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003, 112:257-269.
35. Elbashir S.M., Martinez J., Patkaniowska A., Lendeckel W., Tuschl T. Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. The EMBO Journal 2001, 20:6877-6888.
36. Ellis P., Fagan B.M., Magness S.T., Hutton S., Taranova O., Hayashi S., et al. SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult. Developmental Neuroscience 2004, 26:148-165.
37. Faghihi M.A., Modarresi F., Khalil A.M., Wood D.E., Sahagan B.G., Morgan T.E., et al. Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of beta-secretase. Nature Medicine 2008, 14:723-730.
38. Fantes J., Ragge N.K., Lynch S.A., McGill N.I., Collin J.R., Howard-Peebles P.N., et al. Mutations in SOX2 cause anophthalmia. Nature Genetics 2003, 33:461-463.
39. Fatemi S.H., Folsom T.D., Kneeland R.E., Liesch S.B. Metabotropic glutamate receptor 5 upregulation in children with autism is associated with underexpression of both Fragile X mental retardation protein and GABAA receptor beta 3 in adults with autism. Anatomical Record 2011, 294:1635-1645.
40. Favaro R., Valotta M., Ferri A.L., Latorre E., Mariani J., Giachino C., et al. Hippocampal development and neural stem cell maintenance require Sox2-dependent regulation of Shh. Nature Neuroscience 2009, 12:1248-1256.
41. Feng J., Bi C., Clark B.S., Mady R., Shah P., Kohtz J.D. The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes and Development 2006, 20:1470-1484.
42. Ferri A.L., Cavallaro M., Braida D., Di Cristofano A., Canta A., Vezzani A., et al. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Development 2004, 131:3805-3819.
43. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009, 19:92-105.
44. Gadow K.D., Roohi J., DeVincent C.J., Kirsch S., Hatchwell E. Association of COMT (Val158Met) and BDNF (Val66Met) gene polymorphisms with anxiety, ADHD and tics in children with autism spectrum disorder. Journal of Autism and Developmental Disorders 2009, 39:1542-1551.
45. Garber K.B., Visootsak J., Warren S.T. Fragile X syndrome. European Journal of Human Genetics 2008, 16:666-672.
46. Grant S.G. Synaptopathies: Diseases of the synaptome. Current Opinion in Neurobiology 2012, 22:522-529.
47. Grosso A.R., Gomes A.Q., Barbosa-Morais N.L., Caldeira S., Thorne N.P., Grech G., et al. Tissue-specific splicing factor gene expression signatures. Nucleic Acids Research 2008, 36:4823-4832.
48. Guidi S., Bonasoni P., Ceccarelli C., Santini D., Gualtieri F., Ciani E., et al. Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathology 2008, 18:180-197.
49. Guo H., Ingolia N.T., Weissman J.S., Bartel D.P. Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 2010, 466:835-840.
50. Gupta R.A., Shah N., Wang K.C., Kim J., Horlings H.M., Wong D.J., et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 2010, 464:1071-1076.
51. Hock C., Heese K., Hulette C., Rosenberg C., Otten U. Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Archives of Neurology 2000, 57:846-851.
52. Hogart A., Nagarajan R.P., Patzel K.A., Yasui D.H., Lasalle J.M. 15q11-13 GABAA receptor genes are normally biallelically expressed in brain yet are subject to epigenetic dysregulation in autism-spectrum disorders. Human Molecular Genetics 2007, 16:691-703.
53. Horch H.W., Katz L.C. BDNF release from single cells elicits local dendritic growth in nearby neurons. Nature Neuroscience 2002, 5:1177-1184.
54. Horder J., Lavender T., Mendez M.A., O'Gorman R., Daly E., Craig M.C., et al. Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: A [(1)H]MRS study. Translational Psychiatry 2013, 3:e279.
55. Horsthemke B., Wagstaff J. Mechanisms of imprinting of the Prader-Willi/Angelman region. American Journal of Medical Genetics. Part A 2008, 146A:2041-2052.
56. Howells D.W., Porritt M.J., Wong J.Y., Batchelor P.E., Kalnins R., Hughes A.J., et al. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra. Experimental Neurology 2000, 166:127-135.
57. Hsieh J., Eisch A.J. Epigenetics, hippocampal neurogenesis, and neuropsychiatric disorders: Unraveling the genome to understand the mind. Neurobiology of Disease 2010, 39:73-84.
58. Hu V.W. The expanding genomic landscape of autism: Discovering the 'forest' beyond the 'trees'. Future Neurology 2013, 8:29-42.
59. Hu V.W., Sarachana T., Kim K.S., Nguyen A., Kulkarni S., Steinberg M.E., et al. Gene expression profiling differentiates autism case-controls and phenotypic variants of autism spectrum disorders: Evidence for circadian rhythm dysfunction in severe autism. Autism Research 2009, 2:78-97.
60. Huttenlocher P.R., Dabholkar A.S. Regional differences in synaptogenesis in human cerebral cortex. Journal of Comparative Neurology 1997, 387:167-178.
61. Hutvágner G., Zamore P.D. A microRNA in a multiple-turnover RNAi enzyme complex. Science 2002, 297:2056-2060.
62. Ibáñez-Ventoso C., Vora M., Driscoll M. Sequence relationships among C. elegans, D. melanogaster and human microRNAs highlight the extensive conservation of microRNAs in biology. PLoS One 2008, 3:e2818.
63. Impagnatiello F., Guidotti A.R., Pesold C., Dwivedi Y., Caruncho H., Pisu M.G., et al. A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:15718-15723.
64. Investigators, Autism and Developmental Disabilities Monitoring Network Surveillance Year 2008 Principal, & Prevention, Centers for Disease Control Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 sites, United States, 2008. MMWR Surveillance Summaries 2012, 61:1-19.
65. Ishibashi M., Kogo R., Shibata K., Sawada G., Takahashi Y., Kurashige J., et al. Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma. Oncology Reports 2013, 29:946-950.
66. Jalali S., Jayaraj G.G., Scaria V. Integrative transcriptome analysis suggest processing of a subset of long non-coding RNAs to small RNAs. Biology Direct 2012, 7:25.
67. Ji P., Diederichs S., Wang W., Böing S., Metzger R., Schneider P.M., et al. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
68. Jiang J., Jing Y., Cost G., Chiang J., Kolpa H., Cotton A., et al. Translating dosage compensation to trisomy 21. Nature 2013, 500:296-300.
69. Johnsson P., Ackley A., Vidarsdottir L., Lui W.O., Corcoran M., Grandér D., et al. A pseudogene long-noncoding-RNA network regulates PTEN transcription and translation in human cells. Nature Structural and Molecular Biology 2013, 20:440-446.
70. Kapranov P., Cheng J., Dike S., Nix D.A., Duttagupta R., Willingham A.T., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
71. Katoh-Semba R., Wakako R., Komori T., Shigemi H., Miyazaki N., Ito H., et al. Age-related changes in BDNF protein levels in human serum: Differences between autism cases and normal controls. International Journal of Developmental Neuroscience 2007, 25:367-372.
72. Keniry A., Oxley D., Monnier P., Kyba M., Dandolo L., Smits G., et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nature Cell Biology 2012, 14:659-665.
73. Kerin T., Ramanathan A., Rivas K., Grepo N., Coetzee G.A., Campbell D.B. A noncoding RNA antisense to moesin at 5p14.1 in autism. Science Translational Medicine 2012, 4:128ra140.
74. Khalil A.M., Faghihi M.A., Modarresi F., Brothers S.P., Wahlestedt C. A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome. PLoS One 2008, 3:e1486.
75. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nature Reviews. Molecular Cell Biology 2009, 10:126-139.
76. Kishino T., Lalande M., Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nature Genetics 1997, 15:70-73.
77. Kogo R., Shimamura T., Mimori K., Kawahara K., Imoto S., Sudo T., et al. Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Research 2011, 71:6320-6326.
78. Krebs M.O., Guillin O., Bourdell M.C., Schwartz J.C., Olie J.P., Poirier M.F., et al. Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia. Molecular Psychiatry 2000, 5:558-562.
79. Krek A., Grün D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., et al. Combinatorial microRNA target predictions. Nature Genetics 2005, 37:495-500.
80. Kuwajima T., Nishimura I., Yoshikawa K. Necdin promotes GABAergic neuron differentiation in cooperation with Dlx homeodomain proteins. Journal of Neuroscience 2006, 26:5383-5392.
81. Ladd P.D., Smith L.E., Rabaia N.A., Moore J.M., Georges S.A., Hansen R.S., et al. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Human Molecular Genetics 2007, 16:3174-3187.
82. Lai E.C. Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation. Nature Genetics 2002, 30:363-364.
83. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
84. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Human Molecular Genetics 2007, 16:129-141.
85. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
86. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nature Reviews. Neuroscience 2005, 6:312-324.
87. Li H., Li W.X., Ding S.W. Induction and suppression of RNA silencing by an animal virus. Science 2002, 296:1319-1321.
88. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997, 275:1943-1947.
89. Lin M., Pedrosa E., Shah A., Hrabovsky A., Maqbool S., Zheng D., et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS One 2011, 6:e23356.
90. Lipovich L., Dachet F., Cai J., Bagla S., Balan K., Jia H., et al. Activity-dependent human brain coding/noncoding gene regulatory networks. Genetics 2012, 192:1133-1148.
91. Lipovich L., Tarca A.L., Cai J., Jia H., Chugani H.T., Sterner K.N., et al. Developmental changes in the transcriptome of human cerebral cortex tissue: Long noncoding RNA transcripts. Cerebral Cortex 2013, 10.1093/cercor/bhs414.
92. Liu Q.R., Lu L., Zhu X.G., Gong J.P., Shaham Y., Uhl G.R. Rodent BDNF genes, novel promoters, novel splice variants, and regulation by cocaine. Brain Research 2006, 1067:1-12.
93. Loesch D.Z., Godler D.E., Evans A., Bui Q.M., Gehling F., Kotschet K.E., et al. Evidence for the toxicity of bidirectional transcripts and mitochondrial dysfunction in blood associated with small CGG expansions in the FMR1 gene in patients with parkinsonism. Genetics in Medicine 2011, 13:392-399.
94. Luteijn M.J., Ketting R.F. PIWI-interacting RNAs: From generation to transgenerational epigenetics. Nature Reviews. Genetics 2013, 14:523-534.
95. Lytle J.R., Yario T.A., Steitz J.A. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:9667-9672.
96. Martignetti J.A., Brosius J. BC200 RNA: A neural RNA polymerase III product encoded by a monomeric Alu element. Proceedings of the National Academy of Sciences of the United States of America 1993, 90:11563-11567.
97. Martinez J., Patkaniowska A., Urlaub H., Lührmann R., Tuschl T. Single-stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002, 110:563-574.
98. Matera A.G., Terns R.M., Terns M.P. Non-coding RNAs: Lessons from the small nuclear and small nucleolar RNAs. Nature Reviews. Molecular Cell Biology 2007, 8:209-220.
99. Mattick J.S., Makunin I.V. Small regulatory RNAs in mammals. Human Molecular Genetics 2005, 14(Spec. No. 1):R121-R132.
100. Meng L., Person R.E., Beaudet A.L. Ube3a-ATS is an atypical RNA polymerase II transcript that represses the paternal expression of Ube3a. Human Molecular Genetics 2012, 21:3001-3012.
101. Mercer T.R., Dinger M.E., Mattick J.S. Long non-coding RNAs: Insights into functions. Nature Reviews. Genetics 2009, 10:155-159.
102. Mercer T.R., Dinger M.E., Sunkin S.M., Mehler M.F., Mattick J.S. Specific expression of long noncoding RNAs in the mouse brain. Proceedings of the National Academy of Sciences of the United States of America 2008, 105:716-721.
103. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Human Molecular Genetics 2000, 9:1415-1423.
104. Ming G.L., Song H. Adult neurogenesis in the mammalian central nervous system. Annual Review of Neuroscience 2005, 28:223-250.
105. Morikawa T., Manabe T. Aberrant regulation of alternative pre-mRNA splicing in schizophrenia. Neurochemistry International 2010, 57:691-704.
106. Moseley M.L., Zu T., Ikeda Y., Gao W., Mosemiller A.K., Daughters R.S., et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nature Genetics 2006, 38:758-769.
107. Muddashetty R., Khanam T., Kondrashov A., Bundman M., Iacoangeli A., Kremerskothen J., et al. Poly(A)-binding protein is associated with neuronal BC1 and BC200 ribonucleoprotein particles. Journal of Molecular Biology 2002, 321:433-445.
108. Mus E., Hof P.R., Tiedge H. Dendritic BC200 RNA in aging and in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10679-10684.
109. Nagano T., Fraser P. No-nonsense functions for long noncoding RNAs. Cell 2011, 145:178-181.
110. Nagano T., Mitchell J.A., Sanz L.A., Pauler F.M., Ferguson-Smith A.C., Feil R., et al. The Air noncoding RNA epigenetically silences transcription by targeting G9a to chromatin. Science 2008, 322:1717-1720.
111. Nakata K., Lipska B.K., Hyde T.M., Ye T., Newburn E.N., Morita Y., et al. DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:15873-15878.
112. Neves-Pereira M., Cheung J.K., Pasdar A., Zhang F., Breen G., Yates P., et al. BDNF gene is a risk factor for schizophrenia in a Scottish population. Molecular Psychiatry 2005, 10:208-212.
113. Ng S.Y., Johnson R., Stanton L.W. Human long non-coding RNAs promote pluripotency and neuronal differentiation by association with chromatin modifiers and transcription factors. The EMBO Journal 2012, 31:522-533.
114. Nicholls R.D., Knepper J.L. Genome organization, function, and imprinting in Prader-Willi and Angelman syndromes. Annual Review of Genomics and Human Genetics 2001, 2:153-175.
115. Nieto R., Kukuljan M., Silva H. BDNF and schizophrenia: From neurodevelopment to neuronal plasticity, learning, and memory. Frontiers in Psychiatry 2013, 4:45.
116. O'Roak B.J., Vives L., Fu W., Egertson J.D., Stanaway I.B., Phelps I.G., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622.
117. Pang K.C., Frith M.C., Mattick J.S. Rapid evolution of noncoding RNAs: Lack of conservation does not mean lack of function. Trends in Genetics 2006, 22:1-5.
118. Pearson J.C., Lemons D., McGinnis W. Modulating Hox gene functions during animal body patterning. Nature Reviews. Genetics 2005, 6:893-904.
119. Penny G.D., Kay G.F., Sheardown S.A., Rastan S., Brockdorff N. Requirement for Xist in X chromosome inactivation. Nature 1996, 379:131-137.
120. Persico A.M., D'Agruma L., Maiorano N., Totaro A., Militerni R., Bravaccio C., et al. Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Molecular Psychiatry 2001, 6:150-159.
121. Petanjek Z., Judaš M., Šimic G., Rasin M.R., Uylings H.B., Rakic P., et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:13281-13286.
122. Plath K., Fang J., Mlynarczyk-Evans S.K., Cao R., Worringer K.A., Wang H., et al. Role of histone H3 lysine 27 methylation in X inactivation. Science 2003, 300:131-135.
123. Poliseno L., Salmena L., Zhang J., Carver B., Haveman W.J., Pandolfi P.P. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 2010, 465:1033-1038.
124. Pollard K.S., Salama S.R., Lambert N., Lambot M.A., Coppens S., Pedersen J.S., et al. An RNA gene expressed during cortical development evolved rapidly in humans. Nature 2006, 443:167-172.
125. Ponjavic J., Oliver P.L., Lunter G., Ponting C.P. Genomic and transcriptional co-localization of protein-coding and long non-coding RNA pairs in the developing brain. PLoS Genetics 2009, 5:e1000617.
126. Ponting C.P., Oliver P.L., Reik W. Evolution and functions of long noncoding RNAs. Cell 2009, 136:629-641.
127. Pruunsild P., Kazantseva A., Aid T., Palm K., Timmusk T. Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters. Genomics 2007, 90:397-406.
128. Qin R., Chen Z., Ding Y., Hao J., Hu J., Guo F. Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis. Neoplasma 2013, 60:486-492.
129. Reif A., Fritzen S., Finger M., Strobel A., Lauer M., Schmitt A., et al. Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Molecular Psychiatry 2006, 11:514-522.
130. Ricci S., Businaro R., Ippoliti F., Lo Vasco V.R., Massoni F., Onofri E., et al. Altered cytokine and BDNF levels in autism spectrum disorder. Neurotoxicity Research 2013, 24:491-501.
131. Rinn J.L., Chang H.Y. Genome regulation by long noncoding RNAs. Annual Review of Biochemistry 2012, 81:145-166.
132. Rinn J.L., Kertesz M., Wang J.K., Squazzo S.L., Xu X., Brugmann S.A., et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 2007, 129:1311-1323.
133. Ross-Inta C., Omanska-Klusek A., Wong S., Barrow C., Garcia-Arocena D., Iwahashi C., et al. Evidence of mitochondrial dysfunction in fragile X-associated tremor/ataxia syndrome. The Biochemical Journal 2010, 429:545-552.
134. Rougeulle C., Cardoso C., Fontés M., Colleaux L., Lalande M. An imprinted antisense RNA overlaps UBE3A and a second maternally expressed transcript. Nature Genetics 1998, 19:15-16.
135. Samaco R.C., Hogart A., LaSalle J.M. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Human Molecular Genetics 2005, 14:483-492.
136. Sayed D., Abdellatif M. MicroRNAs in development and disease. Physiological Reviews 2011, 91:827-887.
137. Seila A.C., Calabrese J.M., Levine S.S., Yeo G.W., Rahl P.B., Flynn R.A., et al. Divergent transcription from active promoters. Science 2008, 322:1849-1851.
138. Singer O., Marr R.A., Rockenstein E., Crews L., Coufal N.G., Gage F.H., et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nature Neuroscience 2005, 8:1343-1349.
139. Sleutels F., Zwart R., Barlow D.P. The non-coding Air RNA is required for silencing autosomal imprinted genes. Nature 2002, 415:810-813.
140. Song R., Hennig G.W., Wu Q., Jose C., Zheng H., Yan W. Male germ cells express abundant endogenous siRNAs. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:13159-13164.
141. St Pourcain B., Wang K., Glessner J.T., Golding J., Steer C., Ring S.M., et al. Association between a high-risk autism locus on 5p14 and social communication spectrum phenotypes in the general population. The American Journal of Psychiatry 2010, 167:1364-1372.
142. Sullivan P.F., Kendler K.S., Neale M.C. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Archives of General Psychiatry 2003, 60:1187-1192.
143. Taft R.J., Pheasant M., Mattick J.S. The relationship between non-protein-coding DNA and eukaryotic complexity. Bioessays 2007, 29:288-299.
144. Tam O.H., Aravin A.A., Stein P., Girard A., Murchison E.P., Cheloufi S., et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 2008, 453:534-538.
145. Tanaka J., Horiike Y., Matsuzaki M., Miyazaki T., Ellis-Davies G.C., Kasai H. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 2008, 319:1683-1687.
146. Taylor M.S., Devon R.S., Millar J.K., Porteous D.J. Evolutionary constraints on the disrupted in schizophrenia locus. Genomics 2003, 81:67-77.
147. Tiedge H., Chen W., Brosius J. Primary structure, neural-specific expression, and dendritic location of human BC200 RNA. Journal of Neuroscience 1993, 13:2382-2390.
148. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular Cell 2010, 39:925-938.
149. Uhde C.W., Vives J., Jaeger I., Li M. Rmst is a novel marker for the mouse ventral mesencephalic floor plate and the anterior dorsal midline cells. PLoS One 2010, 5:e8641.
150. Vallot C., Huret C., Lesecque Y., Resch A., Oudrhiri N., Bennaceur-Griscelli A., et al. XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells. Nature Genetics 2013, 45:239-241.
151. Vlietstra R.J., van Alewijk D.C., Hermans K.G., van Steenbrugge G.J., Trapman J. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Research 1998, 58:2720-2723.
152. Voineagu I., Wang X., Johnston P., Lowe J.K., Tian Y., Horvath S., et al. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 2011, 474:380-384.
153. Wang X.H., Aliyari R., Li W.X., Li H.W., Kim K., Carthew R., et al. RNA interference directs innate immunity against viruses in adult Drosophila. Science 2006, 312:452-454.
154. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Molecular Cell 2011, 43:904-914.
155. Wang P., Ren Z., Sun P. Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation. Journal of Cellular Biochemistry 2012, 113:1868-1874.
156. Wang K., Zhang H., Ma D., Bucan M., Glessner J.T., Abrahams B.S., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
157. Watanabe T., Totoki Y., Toyoda A., Kaneda M., Kuramochi-Miyagawa S., Obata Y., et al. Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in mouse oocytes. Nature 2008, 453:539-543.
158. Watson P., Black G., Ramsden S., Barrow M., Super M., Kerr B., et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. Journal of Medical Genetics 2001, 38:224-228.
159. Wegiel J., Kuchna I., Nowicki K., Imaki H., Marchi E., Ma S.Y., et al. The neuropathology of autism: Defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathologica 2010, 119:755-770.
160. Wheeler E., Huang N., Bochukova E.G., Keogh J.M., Lindsay S., Garg S., et al. Genome-wide SNP and CNV analysis identifies common and low-frequency variants associated with severe early-onset obesity. Nature Genetics 2013, 45:513-517.
161. Wienholds E., Plasterk R.H. MicroRNA function in animal development. FEBS Letters 2005, 579:5911-5922.
162. Winter J., Jung S., Keller S., Gregory R.I., Diederichs S. Many roads to maturity: MicroRNA biogenesis pathways and their regulation. Nature Cell Biology 2009, 11:228-234.
163. Wonders C.P., Anderson S.A. The origin and specification of cortical interneurons. Nature Reviews. Neuroscience 2006, 7:687-696.
164. Xia J., Joyce C.E., Bowcock A.M., Zhang W. Noncanonical microRNAs and endogenous siRNAs in normal and psoriatic human skin. Human Molecular Genetics 2013, 22:737-748.
165. Yamasaki K., Joh K., Ohta T., Masuzaki H., Ishimaru T., Mukai T., et al. Neurons but not glial cells show reciprocal imprinting of sense and antisense transcripts of Ube3a. Human Molecular Genetics 2003, 12:837-847.
166. Yang N., Kazazian H.H. L1 retrotransposition is suppressed by endogenously encoded small interfering RNAs in human cultured cells. Nature Structural & Molecular Biology 2006, 13:763-771.
167. Ying L., Huang Y., Chen H., Wang Y., Xia L., Chen Y., et al. Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Molecular BioSystems 2013, 9:407-411.
168. Yotova I.Y., Vlatkovic I.M., Pauler F.M., Warczok K.E., Ambros P.F., Oshimura M., et al. Identification of the human homolog of the imprinted mouse Air non-coding RNA. Genomics 2008, 92:464-473.
169. Zhang X., Gejman R., Mahta A., Zhong Y., Rice K.A., Zhou Y., et al. Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression. Cancer Research 2010, 70:2350-2358.
170. Zhang X., Zhou Y., Mehta K.R., Danila D.C., Scolavino S., Johnson S.R., et al. A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells. Journal of Clinical Endocrinology and Metabolism 2003, 88:5119-5126.
171. Zhao J., Dahle D., Zhou Y., Zhang X., Klibanski A. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. Journal of Clinical Endocrinology and Metabolism 2005, 90:2179-2186.
172. Ziats M.N., Rennert O.M. Aberrant expression of long noncoding RNAs in autistic brain. Journal of Molecular Neuroscience 2013, 49:589-593.
173. Zoghbi H.Y. Postnatal neurodevelopmental disorders: Meeting at the synapse?. Science 2003, 302:826-830.